Cite

HARVARD Citation

    Hölttä, M. et al. (2016). A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Alzheimer's research & therapy. 8 (1), pp. 1-8. [Online]. 
  
Back to record